Private equity firms Bain Capital and Blackstone are frontrunners in the auction for Vitabiotics, a prominent UK vitamin manufacturer. Both firms, along with EQT and TPG, have advanced to the next bidding round. The deal could value the business at approximately £900 million, or $1.2 billion, although negotiations are still ongoing.

Vitabiotics, known for brands like Wellman and Wellwoman, is led by CEO Tej Lalvani and was founded by Kartar Lalvani. This sale highlights continued investor appetite for resilient consumer health businesses, even amidst a more cautious dealmaking environment in the UK mid-market. The vitamins and supplements sector often weathers economic downturns well.

The interest from major private equity players signals confidence in Vitabiotics's brand strength and recurring revenue streams. Such businesses have proven attractive during periods of market uncertainty. The final outcome – and the winning bidder – will be closely watched.

Next steps involve further due diligence and final bids. The transaction's completion would offer a significant return for the current shareholders. The sale also indicates the ongoing interest in the consumer health sector.